Yahoo Web Search

Search results

    • J&J issues cautious 2023 forecast, shares fall

      J&J issues cautious 2023 forecast, shares fall

      Reuters via Yahoo Finance· 1 year ago

      Johnson & Johnson on Tuesday cautioned investors over the lingering impact of inflation-driven costs this year as the healthcare conglomerate issued a...

    • U.S. Medicare Drug-Price Negotiations Start Now

      U.S. Medicare Drug-Price Negotiations Start Now

      The Wall Street Journal· 3 months ago

      HEALTH NEWS The long-awaited and hotly contested drug-price negotiations between the U.S. government and pharmaceutical companies are finally kicking...

    • JNJ Beats on Q3 Earnings: ETFs in Focus

      JNJ Beats on Q3 Earnings: ETFs in Focus

      Zacks via Yahoo Finance· 2 years ago

      Johnson & Johnson JNJ set the ball rolling for the pharma and medical device manufacturer space’s third-quarter 2022 earnings on Oct 18, before the...